TSPFX Mutual Fund

TSPFX Mutual Fund

NAV$5.22
See how much of TSPFX you already own
Just $25 once·$99/mo·Download sample
X-ray my portfolio free

Fund Essentials - as of Aug 31, 2026

Net Assets
$124,647.75
Expense Ratio
1.15%
Dividend Yield (Current)
-
Holdings
64
Inception Date
Mar 10, 2017
Fund Family
Transamerica
Investment Style
PRO
Asset Class
PRO
Legal Structure
PRO

Performance

YTD-1.14%
1 Year-0.03%
3 Year+3.27%
5 Year-2.02%
10 Year+7.32%

Asset Allocation

Stocks: 100.00%
See how much of TSPFX you already own
Your funds unpacked, overlap, fees and score, free on screen. The full report comes with FundXLS. Download sample.
X-ray my portfolio free

Top Holdings

View All →
TickerNameWeight
LGNDLigand Pharmaceuticals, Inc.4.42%
OIIOceaneering International Inc3.30%
CHYMChime Financial Inc Class A3.01%
EEExcelerate Energy, Inc.2.88%
HQYHealthequity Inc2.64%
Top 10 Concentration: 28.86%Report Date: Aug 31, 2026
Download all 64 holdings for TSPFX
CSV export with sector, industry & share changes
Get CSV

Dividend Summary

View Details →
Latest Distribution
$0.97
-

Peer Comparison

Benchmark
PRO
Peer outperformance: PRO
Category rank: PRO
This Mutual Fund
PRO
Peer Avg
PRO

TSPFX Mutual Fund Overview

TSPFX Mutual Fund (Transamerica Small Cap Growth Fund Class R4) is managed by Transamerica with $124,647.75 in net assets. TSPFX expense ratio is 1.15%, holding 64 positions across sectors including Industrials, Health Care, Information Technology. Inception date: 2017-03-10.

TSPFX performance shows a YTD return of -1.14%. The 1-year return is -0.03% and the 5-year return is -2.02%.

TSPFX top holdings include Ligand Pharmaceuticals, Inc. (4.4%), Oceaneering International Inc (3.3%), Chime Financial Inc Class A (3.0%), Excelerate Energy, Inc. (2.9%), Healthequity Inc (2.6%). Go to all TSPFX holdings, TSPFX sectors, or TSPFX dividends.

TSPFX can be compared against other funds. Use TSPFX overlap to find shared positions, or TSPFX vs another fund for a side-by-side view. TSPFX alternatives are available via the screener, along with tax-loss harvesting opportunities.